followed another alternative method.6b Compound 613 was
obtained following the procedure for the preparation of 4
described below.
C, 68.0; H, 7.8; N, 6.4. Calc. for C25H34N2O3S: C, 67.8; H, 7.7;
N, 6.3%.
8 (Minor): mp 158–160 ЊC, [α]2D5 = Ϫ37.7 (c 0.45, CHCl3).
1H NMR (CDCl3) δ 0.95 (3H, s), 1.13 (3H, s), 1.30–1.50 (4H,
m), 1.71–2.45 (11H, m), 2.76 (1H, d, J = 9.7 Hz), 3.13 (1H, d,
J = 9.7 Hz), 3.27–3.38 (1H, m), 3.40 (1H, d, J = 13.3 Hz), 3.42
(2H, s), 3.70 (1H, d, J = 13.3 Hz), 3.95 (1H, dd, J = 4.4, 7.6 Hz),
7.18–7.34 (5H, m). 13C NMR (CDCl3) δ 19.9, 20.5, 26.6,
26.9, 32.6, 33.0, 38.5, 38.8, 44.1, 47.1, 47.8, 48.1, 53.4, 59.2,
59.9, 63.1, 63.7, 66.6, 126.8, 128.1, 128.5, 139.2, 176.1. MS (EI):
m/z (%) 443 [14, (M ϩ H)ϩ], 379 (25), 352 (4), 229 (7), 200 (100),
91 (99). Found: C, 67.6; H, 7.8; N, 6.4. Calc. for C25H34N2O3S:
C, 67.8; H, 7.7; N, 6.3%.
N-(1-Cyclopent-1-en-1-ylcarbonyl)-(2ЈR)-bornane-10,2-sultam 4
Thionyl chloride (5 ml, 68.5 mmol) was added to a solution of
cyclopent-1-enecarboxylic acid (2.4 g, 21.4 mmol) in CH2Cl2
(20 ml). The solution was allowed to reflux for 2 hours followed
by concentration in vacuo to give the corresponding acid
chloride. MeMgBr (3 M in diethyl ether, 6.7 ml, 20.1 mmol)
was added to a 0 ЊC solution of (2R)-(Ϫ)-bornane-10,2-sultam
(4.3 g, 20.0 mmol) in THF (150 ml). After 0.5 h the acid
chloride in THF (20 ml) was slowly added and the solution was
allowed to stir for 1 h. Addition of NH4Cl (aq. sat., 100 ml) was
followed by dilution with EtOAc (200 ml). The organic phase
was extracted with 2 M NaOH (2 × 100 ml), dried (MgSO4),
filtered and concentrated. Chromatography of the residue
[SiO2, EtOAc–cyclohexane (10–>60%) as eluent] yielded com-
pound 4 (5.5 g, 17.8 mmol, 89%) as a colourless solid in >99%
purity (GC). Mp 148–150 ЊC, [α]2D5 = Ϫ65.7 (c 0.40, CHCl3). 1H
NMR (CDCl3) δ 0.99 (3H, s), 1.23 (3H, s), 1.31–1.46 (2H, m),
1.83–2.09 (7H, m), 2.43–2.82 (4H, m), 3.40 (1H, d, J = 13.6 Hz),
3.51 (1H, d, J = 13.6 Hz), 4.05 (1H, dd, J = 4.9, 7.3 Hz), 6.68–
6.74 (1H, m). 13C NMR (CDCl3) δ 19.8, 21.2, 22.5, 26.4, 32.5,
33.1, 34.0, 38.3, 45.1, 47.6, 47.9, 53.5, 65.5, 137.8, 144.3, 167.3.
MS (EI): m/z (%) 310 [30, (M ϩ H)ϩ], 95 (100). Found: C, 62.2;
H, 7.6; N, 4.6. Calc. for C16H23NO3S: C, 62.1; H, 7.5; N, 4.5%.
N-{(3aS,6aS)-2-[(1R)-1-Phenylethyl]octahydrocyclopenta[c]-
pyrrol-3a-ylcarbonyl}-(2R)-bornane-10,2-sultam 11
The title compound was prepared from compound 4 (700 mg,
2.26 mmol) and (R)-N-(1-phenylethyl)-N-(methoxymethyl)-N-
(trimethylsilylmethyl)amine (3, 1.68 g, 6.68 mmol) following
the same procedure as for the preparation of 7 and 8 with the
following exception. The crude product mixture consisting of
two diastereomers (inseparable on silica gel) in a 75 : 25 ratio
(GC) was recrystallised from cyclohexane (60 ml) which
furnished 11 (601 mg, 1.32 mmol, 58%) as a colourless solid in
>99% de (GC) and in chemical purity >99% (GC). Mp 217–219
ЊC, [α]2D5 = ϩ5.7 (c 0.53, CHCl3). 1H NMR (CDCl3) δ 0.95 (3H,
s), 1.18 (3H, s), 1.25 (3H, dd, J = 6.5 Hz), 1.27–2.25 (15H, m),
2.74 (1H, t, J = 8.5 Hz), 3.07 (1H, q, J = 6.5 Hz), 3.25–3.40 (1H,
m), 3.42 (2H, s), 3.80 (1H, d, J = 10.3 Hz), 3.94 (1H, dd, J = 5.0,
7.2 Hz), 7.16–7.30 (5H, m). 13C NMR (CDCl3) δ 19.8, 20.4,
23.1, 26.5, 26.7, 31.3, 32.4, 35.5, 38.5, 44.0, 47.2, 47.9, 48.3,
53.2, 59.7, 62.6, 63.3, 64.7, 66.3, 126.7, 126.9, 128.2, 145.6,
177.3. MS (EI): m/z (%) 457 [14, (M ϩ H)ϩ], 442 (25), 393 (37),
243 (7), 214 (100), 105 (63). Found: C, 68.7; H, 8.0; N, 6.2. Calc.
for C26H36N2O3S: C, 68.4; H, 8.0; N, 6.1%.
N-(2,5-Dihydro-3-thienylcarbonyl)-(2ЈR)-bornane-10,2-sultam 5
Following the same procedure for the preparation of 4 the title
compound (5.7 g, 17.4 mmol, 94%) was obtained as a colourless
solid from (2R)-(Ϫ)-bornane-10,2-sultam (4.0 g, 18.6 mmol)
and 2,5-dihydrothiophene-1-carboxylic acid (2.6 g, 20.0 mmol)
which was prepared from the corresponding methyl ester14
(via hydrolysis, NaOH–H2O–MeOH). Mp 171–173 ЊC, [α]2D5
=
Ϫ98.1 (c 0.59, CHCl3). 1H NMR (CDCl3) δ 1.00 (3H, s),
1.22 (3H, s), 1.30–1.47 (2H, m), 1.82–2.10 (5H, m), 3.42 (1H, d,
J = 13.7 Hz), 3.53 (1H, d, J = 13.7 Hz), 3.83–4.20 (5H, m), 6.71–
6.76 (1H, m). 13C NMR (CDCl3) δ 19.8, 21.2, 26.4, 33.1, 38.0,
38.2, 39.7, 45.1, 47.7, 48.0, 53.5, 65.5, 136.4, 140.2, 165.7. MS
(EI): m/z (%) 327 (80, Mϩ), 263 (50), 113 (100). Found: C, 55.2;
H, 6.4; N, 4.3. Calc. for C15H21NO3S2: C, 55.0; H, 6.5; N, 4.3%.
N-{(3aR,6aR)-2-[(1S)-1-Phenylethyl]octahydrocyclopenta[c]-
pyrrol-3a-ylcarbonyl}-(2R)-bornane-10,2-sultam 10 and
N-{(3aS,6aS)-2-[(1S)-1-phenylethyl]octahydrocyclopenta-
[c]pyrrol-3a-ylcarbonyl}-(2R)-bornane-10,2-sultam 9
To a 110 ЊC solution of compound 4 (1.5 g, 4.85 mmol) in
xylene (mixture of o-, m-, p-isomers, 20 ml) was added (S)-N-
(1-phenylethyl)-N-(methoxymethyl)-N-(trimethylsilylmethyl)-
amine (2, 2.1 g, 8.4 mmol) over a period of 2 h. Full conversion
was achieved after an additional 10 min. The crude product
mixture, consisting of the two diastereomers 10 and 9 in a
80 : 20 ratio (NMR), was worked up using the same protocol as
for the work up of 7 and 8. This afforded the two individual
diastereomers 10 (1.32 g, 2.89 mmol, 59%) and 9 (0.45 g,
0.99 mmol, 20%), both as colourless solids in >99% purity
(GC). The compounds 10 and 9 were diastereomerically pure
according to NMR analyses.
N-[(3aS,6aS)-2-Benzyloctahydrocyclopenta[c]pyrrol-3a-yl-
carbonyl]-(2R)-bornane-10,2-sultam 7 and N-[(3aR,6aR)-2-
benzyloctahydrocyclopenta[c]pyrrol-3a-ylcarbonyl]-(2R)-
bornane-10,2-sultam 8
N-Benzyl-N-(methoxymethyl)trimethylsilylmethylamine (1, 780
mg, 3.3 mmol) was added to a solution of 4 (500 mg, 1.6 mmol)
in a 5 mM solution of TFA–THF (5 ml) over a period of 1.5 h.
After an additional 0.25 h NH4Cl (aq. sat., 25 ml) was added
followed by EtOAc (50 ml). The organic phase was washed with
Na2CO3 (aq. sat., 25 ml), dried (MgSO4), filtered and concen-
trated at 130 ЊC, 1 mbar. The residue which consisted of two
diastereomers 7 and 8 in a 60 : 40 ratio (GC) was purified by
column chromatography [SiO2, EtOAc–cyclohexane (5–60%
as eluent)] to give the two individual pure diastereomers 7
(381 mg, 0.86 mmol, 54%) and 8 (230 mg, 0.52 mmol, 32%).
Both diastereomers were obtained as colourless solids in >200 :
1 diastereomeric ratio (GC).
10 (Major): mp 117–119 ЊC, [α]2D5 = Ϫ74.3 (c 0.54, CHCl3).
1H NMR (CDCl3) δ 0.93 (3H, s), 1.11 (3H, s), 1.30 (3H, d,
J = 6.6 Hz), 1.32–1.49 (4H, m), 1.70–2.15 (9H, m), 2.40 (1H, dd,
J = 4.0, 8.7 Hz), 2.47–2.56 (1H, m), 2.72 (1H, d, J = 10.0 Hz),
2.91 (1H, d, J = 10.0 Hz), 3.18 (1H, q, J = 6.6 Hz), 3.25–3.35
(1H, m), 3.37 (2H, s), 3.94 (1H, dd, J = 4.3, 7.4 Hz), 7.15–7.33
(5H, m). 13C NMR (CDCl3) δ 19.9, 20.5, 22.8, 26.5, 26.6, 32.7
(2 ×C), 38.2, 38.8, 44.2, 46.7, 47.7, 48.0, 53.4, 58.8, 61.7, 63.3,
64.0, 66.7, 126.7, 127.0, 128.1, 145.5, 176.3. MS (EI): m/z (%)
457 [25, (M ϩ H)ϩ], 441 (100), 392 (20), 242 (14), 213 (95), 105
(83). Found: C, 68.7; H, 8.1; N, 6.2. Calc. for C26H36N2O3S: C,
68.4; H, 8.0; N, 6.1%.
7 (Major): mp 92–94 ЊC, [α]2D5 = Ϫ23.4 (c 0.41, CHCl3). H
1
NMR (CDCl3) δ 0.89 (6H, s), 1.20–2.23 (14H, m), 2.34 (1H, d,
J = 10.4 Hz), 2.92 (1H, t, J = 8.4 Hz), 3.29–3.49 (5H, m), 3.61
(1H, d, J = 12.9 Hz), 3.89 (1H, dd, J = 4.8, 7.6 Hz), 7.21–7.32
(5H, m). 13C NMR (CDCl3) δ 19.9, 20.0, 26.5, 26.7, 31.4, 32.4,
35.9, 38.5, 43.9, 47.5, 47.8, 48.1, 53.1, 59.7, 60.4, 63.4, 64.4,
66.3, 126.8, 128.2, 128.7, 138.9, 176.8. MS (EI): m/z (%) 443 [18,
(M ϩ H)ϩ], 379 (30), 352 (5), 229 (5), 200 (100), 91 (68). Found:
9 (Minor): mp 118–121 ЊC, [α]2D5 = Ϫ37.1 (c 0.52, CHCl3). 1H
NMR (CDCl3) δ 0.86 (3H, s), 0.88 (3H, s), 1.31 (3H, d, J =
6.6 Hz), 1.32–2.19 (14H, m), 2.40 (1H, d, J = 10.6 Hz), 2.95 (1H,
t, J = 8.4 Hz), 3.08 (1H, q, J = 6.6 Hz), 3.15 (1H, d, J = 10.6 Hz),
3.28 (1H, d, J = 13.6 Hz), 3.34 (1H, d, J = 13.6 Hz), 3.34–3.45
J. Chem. Soc., Perkin Trans. 1, 2002, 1076–1082
1079